The 12th edition is dedicated to our exciting new developments in pre-clinical cellular models with a particular focus on three-dimensional (3D) cell culture platforms, including microtissues, organoids and organ-on-a-chip systems. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-publishes-ddup-12—evotecs-3d-cell-model-platform-6151